Rule 8.3 - INVERNESS MEDICAL INNOVATIONS INC

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing BARCLAYS PLC (Note 1) Company dealt in INVERNESS MEDICAL INNOVATIONS INC Class of relevant security COM STK USD0.001 to which the dealings being disclosed relate (Note 2) Date of dealing 24 June 2009 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant 2,131,879 2.71% 88,125 0.11% securities (2) Derivatives 0 0.00% (other than options) (3) Options and 119,800 0.15% 53,500 0.07% agreements to purchase/sell Total 2,251,679 2.86% 141,625 0.18% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of Long Short relevant security: Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of Securities Price per unit (GBP) Purchase 400 35.2875 Purchase 2,643 35.1087552 Purchase 100 35.37 Purchase 300 35.46 Purchase 300 35.36 Purchase 2,057 35.36934857 Purchase 500 35.25 Purchase 800 35.09625 Purchase 200 35.36 Purchase 7,200 35.1575 Purchase 300 35.46 Purchase 456 35.52 Purchase 400 35.1625 Purchase 2,972 35.4699428 Purchase 1,800 35.24166667 Purchase 2,200 35.26863636 Purchase 15,000 35.10435867 Purchase 5 35.31 Purchase 80 35.29125 Purchase 20 35.33 Purchase 100 35.45 Purchase 500 35.468 Purchase 1,000 35.42 Purchase 1,100 35.46 Purchase 1,100 35.46 Purchase 3,900 35.44316667 Purchase 200 35.455 Purchase 500 35.31400024 Purchase 22 35.5200 USD Purchase 42 35.5200 USD Purchase 42 35.5200 USD Purchase 44 35.5200 USD Purchase 84 35.5200 USD Purchase 99 35.5200 USD Purchase 100 35.46 Purchase 106 35.5200 USD Purchase 100 35.3384 Purchase 144 35.52 Purchase 2,143 35.5200 USD Purchase 184 35.5200 USD Purchase 1,593 35.34173572 Sale 46 35.4007 USD Sale 1,700 35.42235294 Sale 15,700 34.7399 USD Sale 19 35.5200 USD Sale 34 35.5200 USD Sale 100 35.44 Sale 400 35.2251 USD Sale 282 35.4007 USD Sale 500 35.36 Sale 300 35.46 Sale 220 35.4007 USD Sale 1,100 35.46 Sale 100 35.45 Sale 578 35.4007 USD Sale 500 35.412 Sale 15,000 35.206146 Sale 700 35.40142857 Sale 200 35.44 Sale 100 35.47 Sale 144 35.52 Sale 100 35.3384 Sale 600 35.45583333 Sale 300 35.40666667 Sale 200 35.36 Sale 700 35.40857143 Sale 400 35.4175 Sale 100 35.43 Sale 300 35.36 Sale 200 35.455 Sale 500 35.314 Sale 2,972 35.4699428 Sale 4,460 35.03142601 Sale 2,200 35.2686 Sale 100 35.3384 Sale 17 35.5200 USD Sale 3,449 35.07342128 Sale 2,100 35.26 Sale 1,296 35.05095679 Sale 400 35.46 Sale 800 35.010625 Sale 1,800 35.2417 Sale 1,100 35.10727273 Sale 100 35.42 Sale 100 35.42 Sale 74 35.43 Sale 1,593 35.34173572 Sale 1,700 35.46041176 Sale 1,800 35.24166667 (b) Derivatives transactions (other than options) Product name, Long/Short Number of Price per (e.g. CFD) (Note 6) Securities unit (GBP) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, e.g. Expiry Option money e.g. call selling, securities to price American, date paid/received option purchasing, which the option European etc. per unit (GBP) varying etc. relates (GBP) (ii) Exercising Product name, e.g. Number of Exercise price per call option securities unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION None Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) YES Date of disclosure 25 June 2009 Contact name Geoff Smith Telephone number 020 7116 2913 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) Product name, Written or Number of securities Exercise price Type, e.g. Expiry date e.g. call option purchased to which the option (Note 2) American, or derivative relates European etc. Option Purchased -700 40.0000 AMER 16/01/2010 Option Purchased 100 35.0000 AMER 22/08/2009 Option Purchased 100 25.0000 AMER 20/02/2010 Option Purchased 100 15.0000 AMER 22/01/2011 Option Purchased 100 15.0000 AMER 16/01/2010 Option Purchased -100 25.0000 AMER 21/11/2009 Option Purchased -100 17.5000 AMER 22/08/2009 Option Purchased -100 17.5000 AMER 16/01/2010 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased -23,900 25.0000 AMER 22/08/2009 Option Purchased -600 30.0000 AMER 21/11/2009 Option Purchased 700 35.0000 AMER 16/01/2010 Option Purchased -900 30.0000 AMER 18/07/2009 Option Purchased -1,200 30.0000 AMER 22/01/2011 Option Purchased -2,000 40.0000 AMER 18/07/2009 Option Purchased -2,000 22.5000 AMER 22/08/2009 Option Purchased -2,400 25.0000 AMER 16/01/2010 Option Purchased -2,800 35.0000 AMER 18/07/2009 Option Purchased -4,600 25.0000 AMER 16/01/2010 Option Purchased -11,100 30.0000 AMER 18/07/2009 Option Purchased -500 20.0000 AMER 22/08/2009 Option Purchased 1,600 40.0000 AMER 22/01/2011 Option Purchased 22,300 25.0000 AMER 22/08/2009 Option Purchased 8,400 35.0000 AMER 22/08/2009 Option Purchased 6,900 30.0000 AMER 16/01/2010 Option Purchased 6,400 30.0000 AMER 16/01/2010 Option Purchased 5,700 40.0000 AMER 22/08/2009 Option Purchased 4,400 35.0000 AMER 16/01/2010 Option Purchased 4,400 20.0000 AMER 16/01/2010 Option Purchased 3,100 35.0000 AMER 21/11/2009 Option Purchased 400 50.0000 AMER 21/11/2009 Option Purchased 2,300 45.0000 AMER 16/01/2010 Option Purchased 700 30.0000 AMER 22/08/2009 Option Purchased 1,600 35.0000 AMER 18/07/2009 Option Purchased 1,500 30.0000 AMER 22/08/2009 Option Purchased 1,400 40.0000 AMER 21/11/2009 Option Purchased 1,100 30.0000 AMER 21/11/2009 Option Purchased 1,000 55.0000 AMER 22/01/2011 Option Purchased 1,000 45.0000 AMER 21/11/2009 Option Purchased 900 25.0000 AMER 22/01/2011 Option Purchased 900 22.5000 AMER 22/08/2009 Option Purchased 40,000 35.0000 AMER 22/08/2009 Option Purchased 2,700 50.0000 AMER 16/01/2010 Notes 1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

Companies

Barclays (BARC)
UK 100

Latest directors dealings